The fully linked HTML version of this article has now been published.
Development ePress online publication date 16 Aug 2006
doi: 10.1242/dev.02542
Research report
Gli3-mediated repression of Hedgehog targets is required for normal mammary development
Sarah J. Hatsell
and
Pamela Cowin*
* Author for correspondence (e-mail: cowinp01{at}med.nyu.edu)
The Hedgehog pathway is vital for the development of many epidermal appendages, but its role in mammary development has been unclear. Here, we show that although Gli2 and Gli3 are expressed during embryonic mammary development, transcriptional reporters of positive Hedgehog signaling are absent. Nevertheless, Gli3xt/xt embryos show aberrant early mammary marker expression and lack two pairs of mammary buds, demonstrating that Gli3 is essential for mammary bud formation and preceding patterning events. Misactivation of the Hedgehog pathway by targeted expression of the constitutive activator Gli1, from the Gli2 promoter in Gli3xt/+ mice, also induces mammary bud loss. Moreover, loss of Gli3 expression induces Gli1 misexpression in mammary mesenchyme. These results establish that the essential function of Gli3 during embryonic mammary development is to repress Hedgehog/Gli1-inducible targets. During postnatal mammary development, Gli2 and Gli3 are expressed in stromal and myoepithelial cells, and Gli3 is also found within the lumenal epithelium. Again, transcriptional reporters of positive Hedgehog signaling are absent from these cell types, yet are expressed robustly within mammary lymphatics. Thus, positive Hedgehog signaling is absent throughout mammary development, distinguishing the mammary gland from other epidermal appendages, such as hair follicles, which require Hedgehog pathway activity.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Kasper, V. Jaks, M. Fiaschi, and R. Toftgard
Hedgehog signalling in breast cancer
Carcinogenesis,
June 1, 2009;
30(6):
903 - 911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fiaschi, B. Rozell, A. Bergstrom, and R. Toftgard
Development of Mammary Tumors by Conditional Expression of GLI1
Cancer Res.,
June 1, 2009;
69(11):
4810 - 4817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Moraes, H. Chang, N. Harrington, J. D. Landua, J. T. Prigge, T. F. Lane, B. J. Wainwright, P. A. Hamel, and M. T. Lewis
Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation
Development,
May 1, 2009;
136(9):
1423 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Watson and W. T. Khaled
Mammary development in the embryo and adult: a journey of morphogenesis and commitment
Development,
March 15, 2008;
135(6):
995 - 1003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fiaschi, B. Rozell, A. Bergstrom, R. Toftgard, and M. I. Kleman
Targeted Expression of GLI1 in the Mammary Gland Disrupts Pregnancy-induced Maturation and Causes Lactation Failure
J. Biol. Chem.,
December 7, 2007;
282(49):
36090 - 36101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Bok, D. K. Dolson, P. Hill, U. Ruther, D. J. Epstein, and D. K. Wu
Opposing gradients of Gli repressor and activators mediate Shh signaling along the dorsoventral axis of the inner ear
Development,
May 1, 2007;
134(9):
1713 - 1722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Moraes, X. Zhang, N. Harrington, J. Y. Fung, M.-F. Wu, S. G. Hilsenbeck, D. C. Allred, and M. T. Lewis
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia
Development,
March 15, 2007;
134(6):
1231 - 1242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Hens, P. Dann, J.-P. Zhang, S. Harris, G. W. Robinson, and J. Wysolmerski
BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction
Development,
March 15, 2007;
134(6):
1221 - 1230.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
